Alexander Rudensky
board of directors
BioInvent
Sweden
Biography
Alexander Rudensky, Ph.D., Chair of the Immunology Program at Sloan Kettering Institute. World-leading scientist within the area of regulatory T-cells, specialized in CD4-T cell regulation and homeostasis, and its role in autoimmunity and cancer. The main task of the Scientific Advisory Board, chaired by Professor Martin Glennie, University of Southampton, is to provide BioInvent with valuable input in its effort to develop new antibody treatments for various forms of cancer diseases. The Scientific Advisory Board brings together a wealth of knowledge in the areas of antibody and cancer immunobiology relevant to anti-cancer drug development. BioInvent’s Chief Scientific Officer, Professor Björn Frendéus, has been appointed Secretary of the Scientific Advisory Board, which held its first meeting in London on 14 May 2017.
Research Interest
immunology
